Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tedizolid (DA-7157)is a novel oxazolidinone-class antibiotic that inhibits bacterial protein synthesis by binding to the 23S ribosomal RNA of the 50S subunit of the ribosome.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 9,000 | |||
2 mg | 在庫あり | ¥ 12,500 | |||
5 mg | 在庫あり | ¥ 19,000 | |||
10 mg | 在庫あり | ¥ 33,000 | |||
25 mg | 在庫あり | ¥ 57,000 | |||
50 mg | 在庫あり | ¥ 89,500 | |||
100 mg | 在庫あり | ¥ 130,500 | |||
500 mg | 在庫あり | ¥ 273,500 |
説明 | Tedizolid (DA-7157)is a novel oxazolidinone-class antibiotic that inhibits bacterial protein synthesis by binding to the 23S ribosomal RNA of the 50S subunit of the ribosome. |
In vitro | Tedizolid (0.25 μg/mL) effectively inhibits all 28 clinical isolates of PRSP, demonstrating a potency four times greater than linezolid against PRSP[1]. |
In vivo | The tedizolid phosphate at a minimum total daily dose of 10 mg/kg achieved a 100% survival rate for mice infected with PSSP type III. Lungs of infected mice treated with tedizolid phosphate show less severe inflammation and edema, as indicated by the mean scores for inflammation and edema[1]. |
別名 | TR 700, DA-7157, Torezolid |
分子量 | 370.34 |
分子式 | C17H15FN6O3 |
CAS No. | 856866-72-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 2.8 mg/mL (7.56 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tedizolid 856866-72-3 Metabolism Microbiology/Virology Neuroscience MAO Antibacterial Antibiotic TR 700 TR-700 inhibit DA7157 DA-7157 Bacterial Inhibitor DA 7157 Torezolid TR700 inhibitor